Investors should get hooked on tobacco stocks’ earnings growth and pricing power, Morgan Stanley writes

Tobacco stocks have amassed a mixed record thus far in 2017, and the Food and Drug Administration’s July announcement that it would lower the nicotine levels in cigarettes to nonaddictive levels was seen as adding a new layer of uncertainty for the sector, but they may be well positioned in the event of a broader market pullback.